RESEARCH DATABASE

InBody Scholar

InBody continues to work closely with academic researchers on a global scale to develop more in-depth clinical applications of body composition.
With our long history in the industry, we provide more than 6,000 research and publications.
Research title with ★ indicates InBody recommended paper.

Effect of tofogliflozin on body composition and glycemic control in Japanese subjects with type 2 diabetes mellitus

Endocrinology
Author
S Kamei et al.
Used Parameters : TBW, ICW, ECW, SLM, SMM, Segmental FFM, SMI, VFA
Publication Year : 2017
Country : Japan
Journal : Journal of Diabetes Research
Sodium-glucose cotransporter 2 inhibitor tofogliflozin is a new type of antidiabetic drug for individuals with type 2 diabetes mellitus (T2DM). The aim of this study was to examine in which type of individuals and/or under which conditions tofogliflozin could exert more beneficial effects on body composition and/or glycemic control in Japanese individuals with T2DM. We retrospectively evaluated the effects of tofogliflozin on body composition and/or glycemic control in individuals with T2DM who newly started taking tofogliflozin. After …
Full text
List
Powered by KBoard